Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00543_DB01045> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00543_DB01045 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00543_DB01045 label "DDI between Amoxapine and Rifampicin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, amoxapine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if rifampin is initiated, discontinued or dose changed. [drugbank_resource:DB00543_DB01045]" assertion.
- drugbank_resource:DB00543_DB01045 identifier "drugbank_resource:DB00543_DB01045" assertion.
- drugbank_resource:DB00543_DB01045 title "DDI between Amoxapine and Rifampicin - The rifamycin, rifampin, may decrease the effect of the tricyclic antidepressant, amoxapine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if rifampin is initiated, discontinued or dose changed." assertion.